20380007

Source:http://linkedlifedata.com/resource/pubmed/id/20380007

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0229671, umls-concept:C0280274, umls-concept:C0332281, umls-concept:C0524910, umls-concept:C0547047, umls-concept:C1741190
pubmed:issue	14
pubmed:dateCreated	2010-4-9
pubmed:abstractText	To assess serum concentrations of prohepcidin in chronic hepatitis C individuals and evaluate their associations with disease activity and efficacy of pegylated interferon (PEG-IFN)/ribavirin (RBV) therapy.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/20380007-10847480, http://linkedlifedata.com/resource/pubmed/commentcorrection/20380007-11113131, http://linkedlifedata.com/resource/pubmed/commentcorrection/20380007-11113132, http://linkedlifedata.com/resource/pubmed/commentcorrection/20380007-11447267, http://linkedlifedata.com/resource/pubmed/commentcorrection/20380007-12433676, http://linkedlifedata.com/resource/pubmed/commentcorrection/20380007-14675249, http://linkedlifedata.com/resource/pubmed/commentcorrection/20380007-15514116, http://linkedlifedata.com/resource/pubmed/commentcorrection/20380007-15836704, http://linkedlifedata.com/resource/pubmed/commentcorrection/20380007-16475996, http://linkedlifedata.com/resource/pubmed/commentcorrection/20380007-16835372, http://linkedlifedata.com/resource/pubmed/commentcorrection/20380007-16893896, http://linkedlifedata.com/resource/pubmed/commentcorrection/20380007-16946298, http://linkedlifedata.com/resource/pubmed/commentcorrection/20380007-16979376, http://linkedlifedata.com/resource/pubmed/commentcorrection/20380007-17210448, http://linkedlifedata.com/resource/pubmed/commentcorrection/20380007-17349976, http://linkedlifedata.com/resource/pubmed/commentcorrection/20380007-17464464, http://linkedlifedata.com/resource/pubmed/commentcorrection/20380007-17515961, http://linkedlifedata.com/resource/pubmed/commentcorrection/20380007-17557118, http://linkedlifedata.com/resource/pubmed/commentcorrection/20380007-17559363, http://linkedlifedata.com/resource/pubmed/commentcorrection/20380007-17854465, http://linkedlifedata.com/resource/pubmed/commentcorrection/20380007-17905609, http://linkedlifedata.com/resource/pubmed/commentcorrection/20380007-1808228, http://linkedlifedata.com/resource/pubmed/commentcorrection/20380007-18620776, http://linkedlifedata.com/resource/pubmed/commentcorrection/20380007-18979640, http://linkedlifedata.com/resource/pubmed/commentcorrection/20380007-19729219
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/100883448
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antimicrobial Cationic Peptides, http://linkedlifedata.com/resource/pubmed/chemical/Antiviral Agents, http://linkedlifedata.com/resource/pubmed/chemical/Interferon-alpha, http://linkedlifedata.com/resource/pubmed/chemical/Iron, http://linkedlifedata.com/resource/pubmed/chemical/Polyethylene Glycols, http://linkedlifedata.com/resource/pubmed/chemical/Protein Precursors, http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Ribavirin, http://linkedlifedata.com/resource/pubmed/chemical/interferon alfa-2a, http://linkedlifedata.com/resource/pubmed/chemical/peginterferon alfa-2a, http://linkedlifedata.com/resource/pubmed/chemical/prohepcidin
pubmed:status	MEDLINE
pubmed:month	Apr
pubmed:issn	1007-9327
pubmed:author	pubmed-author:FlisiakIwonaI, pubmed-author:FlisiakRobertR, pubmed-author:JaroszewiczJerzyJ, pubmed-author:RogalskaMagdalenaM
pubmed:issnType	Print
pubmed:day	14
pubmed:volume	16
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1747-52
pubmed:dateRevised	2011-11-17
pubmed:meshHeading	pubmed-meshheading:20380007-Adult, pubmed-meshheading:20380007-Aged, pubmed-meshheading:20380007-Antimicrobial Cationic Peptides, pubmed-meshheading:20380007-Antiviral Agents, pubmed-meshheading:20380007-Female, pubmed-meshheading:20380007-Hepatitis C, Chronic, pubmed-meshheading:20380007-Humans, pubmed-meshheading:20380007-Interferon-alpha, pubmed-meshheading:20380007-Iron, pubmed-meshheading:20380007-Male, pubmed-meshheading:20380007-Middle Aged, pubmed-meshheading:20380007-Polyethylene Glycols, pubmed-meshheading:20380007-Protein Precursors, pubmed-meshheading:20380007-Recombinant Proteins, pubmed-meshheading:20380007-Ribavirin, pubmed-meshheading:20380007-Young Adult
pubmed:year	2010
pubmed:articleTitle	Successful antiviral therapy is associated with a decrease of serum prohepcidin in chronic hepatitis C.
pubmed:affiliation	Department of Infectious Diseases and Hepatology, Medical University of Bialystok, Zurawia Str 14, Bialystok 15-540, Poland.
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't